Close Menu

NEW YORK  – Thermo Fisher Scientific on Wednesday morning reported a 2 percent year-over-year increase in its first quarter 2020 revenues.

Earlier this month, the Waltham, Massachusetts-based company had predicted a 1 to 2 percent increase in Q1 revenues but withdrew its financial guidance for 2020. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.